Suppr超能文献

慢性阻塞性肺疾病的死亡率:病因、危险因素和预防。

Mortality in COPD: causes, risk factors, and prevention.

机构信息

Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

COPD. 2010 Oct;7(5):375-82. doi: 10.3109/15412555.2010.510160.

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading and increasing cause of death, the extent of which is underestimated as a consequence of underdiagnosis and underreporting on death certificates. Data from large trials, such as the Lung Health Study, Towards a Revolution in COPD Health (TORCH), Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT), European Respiratory Society Study on Chronic Obstructive Pulmonary Disease (EUROSCOP), and Inhaled Steroids in Obstructive Lung Disease (ISOLDE), have shown that the causes of death in patients with mild COPD are predominantly cancer and cardiovascular disease, but as COPD severity increases, deaths due to non-malignant respiratory disease are increasingly common. In practice, mortality of patients with COPD can be predicted by a variety of measures including: forced expiratory volume in one second (FEV(1)), the ratio of inspiratory and total lung capacities, exercise capacity, dyspnea scores, and composite indices such as the body-mass index (B), degree of airflow obstruction (O), degree of functional dyspnea (D), and exercise capacity (E) (BODE) index. Smoking cessation improves survival in COPD patients, and in select patients with advanced disease, oxygen therapy, lung volume reduction surgery, or lung transplantation may also improve survival.

摘要

慢性阻塞性肺疾病(COPD)是主要的致死病因,且其致死人数呈上升趋势。由于诊断不足和死亡证明报告不足,其实际致死人数被低估。大型试验的数据,如肺健康研究(Lung Health Study)、COPD 健康革命研究(TORCH)、噻托溴铵对功能潜在长期影响的认识研究(UPLIFT)、欧洲呼吸学会 COPD 研究(EUROSCOP)和吸入性皮质类固醇治疗阻塞性肺病(ISOLDE)表明,轻度 COPD 患者的主要死因是癌症和心血管疾病,但随着 COPD 严重程度的增加,非恶性呼吸道疾病导致的死亡越来越常见。实际上,多种指标都可以预测 COPD 患者的死亡率,包括:第一秒用力呼气量(FEV1)、吸气量与肺总量之比、运动能力、呼吸困难评分以及体质量指数(BMI)、气流阻塞程度(O)、功能性呼吸困难程度(D)和运动能力(E)的综合指数(BODE 指数)。戒烟可改善 COPD 患者的生存状况,对于一些晚期疾病患者,氧疗、肺减容术或肺移植也可能改善生存状况。

相似文献

5

引用本文的文献

本文引用的文献

4
Systemic manifestations and comorbidities of COPD.慢性阻塞性肺疾病的全身表现及合并症
Eur Respir J. 2009 May;33(5):1165-85. doi: 10.1183/09031936.00128008.
5
A 4-year trial of tiotropium in chronic obstructive pulmonary disease.噻托溴铵用于慢性阻塞性肺疾病的4年试验。
N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.
7
Longitudinal change in the BODE index predicts mortality in severe emphysema.BODE指数的纵向变化可预测重度肺气肿患者的死亡率。
Am J Respir Crit Care Med. 2008 Sep 1;178(5):491-9. doi: 10.1164/rccm.200709-1383OC. Epub 2008 Jun 5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验